Trials / Completed
CompletedNCT05095077
Effects of Single Dose Tadalafil on Urethral and Anal Closure Function
Effects of Single Dose Tadalafil on Urethral and Anal Closure Function and on Urinary Flow in Healthy Females: A Randomised, Controlled, Double-blinded, Two-period Cross-over Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- University Hospital Bispebjerg and Frederiksberg · Academic / Other
- Sex
- Female
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the trial is to assess the effect of tadalafil compared to placebo (inactive comparator) on the urethral - and anal pressure and on urine flow in healthy females. Further, the purpose of the trial is to evaluate the potential for going forward with studies of tadalafil in patients suffering from urine or fecal incontinence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tadalafil 40 MG | Single dose on study day 1/2 |
| DRUG | Placebo | Identical to active IMP |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2021-12-30
- Completion
- 2022-01-01
- First posted
- 2021-10-27
- Last updated
- 2022-04-06
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05095077. Inclusion in this directory is not an endorsement.